PunchYour best still to come, Ronaldo tells injured KvaratskheliaThe Jerusalem PostMDA inaugurates 96 new ambulances marking 96 years of lifesaving workESPN Deportes¿Qué equipos pueden clasificar en la jornada doble?ESPNPredictions for all 32 conference players of the yearBollywood HungamaViraj Ghelani and Arjun Tanwar starrer Party Animals trailer out ahead of November 20 releaseRTP DesportoAntónio Salvador aponta o dedo ao plantel do Sp. BragaDaily MaverickGROUNDUP: Tshwane’s drinking water crisis a wake-up call for SA as sewage pollution sickens hundreds
KioskNews
The Daily Newsstand · Free, Always
Wednesday, October 21, 2026
Language
Seeking Alpha·United States·

Cellyan Biotechnology announces 1-for-20 reverse stock split

Translate

Jay Mehta

  • Cellyan Biotechnology (HKPD) said on Wednesday it would implement a 1-for-20 reverse stock split effective Oct. 26.
  • The reverse stock split will increase the par value of the company's Class A and Class B ordinary shares to $0.02 from $0.001 per share.
  • Fractional shares resulting from the split will be rounded up to the nearest whole share.
  • The move was intended to help the company regain compliance with Nasdaq’s minimum bid price requirement.

Recommended For You

Create Your Free Account to Keep Reading

Get the confidence to navigate an uncertain market with free breaking news and stock alerts.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.